THIN-ST® is a prescription-only compounded tirzepatide oral spray (15mg / 10mL) — dual-pathway appetite support, without the injection.
Prescription-only. Compounded medication. Not FDA-approved. Dispensed only if a licensed provider determines it is medically appropriate.
Tirzepatide is a dual-pathway molecule — the same active ingredient class found in Mounjaro® and Zepbound®. THIN-ST delivers it in the same needle-free sublingual spray format, built for eligible patients in the maintenance phase.
Tirzepatide engages two appetite-signaling pathways (GIP and GLP-1) — the same active ingredient class as the leading dual-action injectables.
Needle-free, sublingual, no refrigeration. The convenience of the THIN platform, with the tirzepatide molecule.
Your provider determines whether tirzepatide is the right fit for your history and goals — never one-size-fits-all.
THIN-ST delivers tirzepatide under the tongue — designed to absorb through the oral mucosa instead of being swallowed and broken down in the stomach.
THIN-ST is a 503A compounded medication prepared for an individual patient pursuant to a valid prescription. It is not FDA-approved and is not a replacement for all injectable therapy. Individual results vary.
Includes your telehealth provider, medication, and shipping. No insurance necessary.
Payment does not guarantee that a prescription will be written or dispensed.
Fill out a quick, free medical history form so your provider can build the right plan for you.
Connect with a licensed physician or nurse practitioner through a simple online conversation.
If appropriate, your compounded medication ships to your door with free shipping.
THIN-ST is prescription-only and requires review by a licensed provider. Please consult a healthcare professional before starting, especially if you have a history of medical conditions or take other medications.
THIN-ST is a 503A compounded tirzepatide oral/sublingual spray — prescription-only and patient-specific. Tirzepatide is the same active ingredient class associated with Mounjaro® and Zepbound®. THIN-ST is not FDA-approved.
THIN and THIN-R use semaglutide; THIN-ST uses tirzepatide, a dual-pathway (GIP and GLP-1) molecule. All three are needle-free sublingual sprays on the same THIN platform. Your provider helps determine which is appropriate for you.
THIN-ST is positioned as a needle-free maintenance and appetite-support option — complementary to the existing landscape, not a replacement for all injectable therapy. Your provider will advise what's appropriate.
Dose under the tongue as directed by your prescriber. No refrigeration is required, so it travels easily.
No. One transparent price includes your telehealth provider visit, the medication if prescribed, and free shipping.
No. Your intake information is reviewed independently by a licensed provider, and medication is only prescribed and dispensed if it is medically appropriate. Payment does not guarantee prescribing or dispensing.
Start your THIN-ST evaluation today and see if needle-free, dual-pathway maintenance support may be right for you.
Start Your THIN-ST Evaluation